Senate HELP Committee to Meet for Final Time for Biomedical Innovation Legislation | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

Senate HELP Committee to Meet for Final Time for Biomedical Innovation Legislation

April 4, 2016
by Rajiv Leventhal
| Reprints

This week, the U.S. Senate Committee for Health, Education, Labor and Pensions (HELP) committee will hold its third and final executive session to consider several bipartisan biomedical innovation bills.

During the April 6 meeting, the committee will vote on at least five bipartisan bills, finishing its work on companion legislation to the House’s 21st Century Cures Act with a parallel effort to modernize the Food and Drug Administration and the National Institutes of Health (NIH) to bring safe drugs and medical devices to American patients more quickly and safely, the committee said in a statement.

The bills slated for consideration at the April 6 committee meeting include:

  • Sens. Lamar Alexander (R-Tenn.) and Patty Murray (D-Wash.) - FDA and NIH Workforce Authorities Modernization Act (S. 2700);
  • Sens. Orrin Hatch (R-Utah) and Michael Bennet (D-Colo.) – Promise for Antibiotics and Therapeutics for Health Act (S. 185).
  • Sens. Lamar Alexander (R-Tenn.) and Patty Murray (D-Wash.) – Advancing Precision Medicine Act of 2016 (S. 2713):
  • Sens. Susan Collins (R-Maine), Elizabeth Warren (D-Mass.), Mark Kirk (R-Ill.), Tammy Baldwin (D-Wisc.), Lamar Alexander (R-Tenn.), and Patty Murray (D-Wash.) – NIH Strategic Plan and Inclusion in Clinical Research; and
  • Sens. Alexander (R-Tenn.) and Patty Murray (D-Wash.) – Promoting Biomedical Research and Public Health for Patients Act.

On January 19, Senate Help Chairman Lamar Alexander released the committee’s mark-up schedule for step-by-step consideration of biomedical innovation bills. Then, on Feb. 9, the Senate health committee kicked off its biomedical innovation agenda, passing seven bills with bipartisan support. On March 9, the committee passed seven more bipartisan biomedical innovation bills.

At the committee’s March 9 Innovation meeting, Alexander said, “This year, the most important opportunity that everybody wants to take advantage of is this remarkable scientific opportunity in biomedical research. It offers the promise of help for virtually every American. And I believe if we would succeed, it will be the most important piece of legislation signed into law this year.  … I do not know of another way this year to get support for the president’s Precision Medicine Initiative or support for the cancer ‘moonshot’ or a surge for mandatory funding for the National Institutes of Health, unless we act on his bill.”

Regarding mandatory funding for the NIH, Alexander said, “Because of our budget deficit, we need to fund that new surge in mandatory funding by reducing existing mandatory funding. … I pledge to work with Senator Murray and other members of the committee to try to achieve a bipartisan consensus that will arrive on the floor at the same time as this innovation package does. … I think we can produce the most important bill of the Congress this year, because our work on this bill will affect virtually every American. And I look forward to doing it promptly so we can hand to Senator McConnell a conclusion to the Innovation bill and on the surge of funding for NIH through mandatory funding in a bipartisan way, so he can put it on the floor.”

Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.

Learn More

Topics

News

ONC Roundup: Senior Leadership Changes Spark Questions

The Office of the National Coordinator for Health IT (ONC) has continued to experience changes within its upper leadership, leading some folks to again ponder what the health IT agency’s role will be moving forward.

Media Report: Walmart Hires Former Humana Executive to Run Health Unit

Reigniting speculation that Walmart and insurer Humana are exploring ways to forge a closer partnership, Walmart Inc. has hired a Humana veteran to run its health care business, according to a report from Bloomberg.

Value-Based Care Shift Has Halted, Study Finds

A new study of 451 physicians and health plan executives suggests that progress toward value-based care has stalled. In fact, it may have even taken a step backward over the past year, the research revealed.

Study: EHRs Tied with Lower Hospital Mortality, But Only After Systems Have Matured

Over the past decade, there has been significant national investment in electronic health record (EHR) systems at U.S. hospitals, which was expected to result in improved quality and efficiency of care. However, evidence linking EHR adoption to better care is mixed, according to medical researchers.

Nursing Notes Can Help Predict ICU Survival, Study Finds

Researchers at the University of Waterloo in Ontario have found that sentiments in healthcare providers’ nursing notes can be good indicators of whether intensive care unit (ICU) patients will survive.

Health Catalyst Completes Acquisition of HIE Technology Company Medicity

Salt Lake City-based Health Catalyst, a data analytics company, has completed its acquisition of Medicity, a developer of health information exchange (HIE) technology, and the deal adds data exchange capabilities to Health Catalyst’s data, analytics and decision support solutions.